← Browse by Condition
Medical Condition

ret gene mutation

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06109558 Phase 1, Phase 2
Recruiting

The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC

Enrollment
120 pts
Location
China
Sponsor
Hunan Province Tumor Hospital
View Trial →